ROSIVER 1 %
IVERMECTIN : 1 % · DIN 02440342 · GALDERMA CANADA INC
Health Canada status: MARKETED
What is ROSIVER?
ROSIVER 1 % contains IVERMECTIN : 1 %. It is listed in the Health Canada Drug Product Database under DIN 02440342, held by GALDERMA CANADA INC, supplied as CREAM for TOPICAL administration. Health Canada currently lists it as marketed, status dated 25-May-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ROSIVER used for?
Topical treatment of inflammatory lesions (papules and pustules) of rosacea in adults 18 years of age or older.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02440342 |
|---|---|
| Brand name | ROSIVER |
| Generic / active ingredient | IVERMECTIN : 1 % |
| Manufacturer | GALDERMA CANADA INC |
| Strength | 1 % |
| Dosage form | CREAM |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | D11AX22 IVERMECTIN |
| AHFS class | 84:04.12 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 25-May-2015 |
| Original market date | 2015-05-25 00:00:00 |
How is it administered?
Apply once daily at bedtime. Use a pea-size amount for each of the five areas of the face (forehead, chin, nose, each cheek). Spread as a thin layer, avoiding eyes and lips. Wash hands after use.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at room temperature (15°C to 25°C).
How is it supplied?
15 g, 30 g, 45 g and 60 g laminated tubes with a child-resistant cap. Physician samples in 2 g laminate tubes.
Contraindications
Hypersensitivity to ivermectin or to any ingredient in the formulation or component of the container.
Warnings and precautions
May cause aggravation of rosacea; discontinue if severe. Contains cetyl/stearyl alcohol, parabens, and propylene glycol which may cause skin reactions or irritation. Avoid eyes and lips.
What can be used instead?
Other Canadian products sharing ATC code D11AX22 IVERMECTIN. 2 of 2 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PMS-IVERMECTIN | 1 % | CREAM | PHARMASCIENCE INC | MARKETED | DIN 02557363 |
Who else supplies IVERMECTIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. IVERMECTIN appears in 37 registered pack listings across 10 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.